Hospira, Inc.

F. Michael (Mike) Ball has been appointed chief executive officer of Hospira, Inc. and a member of the board, effective March 28, 2011. He succeeds the company’s founding CEO, Christopher B. Begley, who will assume the role of executive chairman.

Mr. Ball currently serves as president of Allergan, Inc., where he has spent the past 16 years of his career. During this time, Mr. Ball was responsible for accelerating growth in international markets and leading the strategy and execution of global commercial activities for specialty pharmaceuticals, OTC products and surgical devices.

“From the outset of our CEO search, the board and I were determined to identify a candidate who would extend Hospira’s growth trajectory, expand our global reach, and inspire our employees as we continue our patient-focused journey to sustainable top-tier financial performance,” said Mr. Begley. “With his proven track record of growing complex global businesses, demonstrated success in leading diversified healthcare portfolios and strong commitment to creating value for all company stakeholders, we found the perfect fit with Mike Ball. We are thrilled to welcome Mike to the Hospira family, and I look forward to partnering with him and our board to continue to advance our great company.”

Mr. Ball said, “I am deeply honored and excited to join Hospira’s 14,000 employees in advancing our shared passion to increase patient and caregiver safety and productivity, reduce the high costs of healthcare, and provide the highest quality products that address critical unmet needs around the globe. With our strong financial position, market leadership and talented workforce, Hospira is uniquely positioned to capitalize on our exceptional growth potential while we create value for our employees, customers, shareholders and global communities.”